SFG
CSBR icon

Steward Financial Group’s Champions Oncology CSBR Stock Holding History

Steward Financial Group’s Portfolio CSBR Stock Details CSBR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		$4K Buy
+775
New +$4.9K ﹤0.01% 704
2023
Q2 		– Sell
-775
Closed -$3K – 584
2023
Q1 		$3K Hold
775
– – ﹤0.01% 399
2022
Q4 		$3K Buy
+775
New +$5.06K ﹤0.01% 253

Other funds holding CSBR

BMC
Battery Management Corp Boston, Massachusetts $426M AUM 21.5% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
TAM
Tocqueville Asset Management New York $6.74B AUM 32.29% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Steward Financial Group's CSBR Position: Q3 2023 in Review

Steward Financial Group opened a new position in Champions Oncology (CSBR) in Q3 2023: 775 shares worth $4K. The stake represents ﹤0.01% of the portfolio and ranks #704 among its holdings. This is a return to the name: Steward Financial Group previously reported a position in CSBR as recently as Q1 2023.

Steward Financial Group first reported a position in CSBR in Q4 2022 and has held it in 3 quarters since. 29 funds tracked by Wall St. Rank hold CSBR as of Q3 2023.

  • Steward Financial Group held 775 shares of Champions Oncology worth $4K as of Q3 2023.
  • Champions Oncology was a new Steward Financial Group position in Q3 2023.
  • Champions Oncology made up ﹤0.01% of Steward Financial Group's portfolio in Q3 2023, its #704 holding.
  • Steward Financial Group first reported a position in Champions Oncology in Q4 2022 and has held it in 3 quarters since.
  • 29 funds tracked by Wall St. Rank held Champions Oncology as of Q3 2023.

Based on Steward Financial Group's 13F filing for Q3 2023, filed 23 Oct 2023.